Genetic variations of PTPN2 and PTPN22: Role in the pathogenesis of Type 1 diabetes and Crohn's disease

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue DEC, 2015, Pages

  Sharp, Robert C ^a   Abdulrahim, Muna ^a   Naser, Ebraheem S ^a   Naser, Saleh A ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Crohn's disease; Genetics; Immunity; PTPN2; PTPN22; PTPs; T1D

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; TRANSCRIPTION FACTOR FOXP3; PTPN2 PROTEIN, HUMAN; PTPN22 PROTEIN, HUMAN;

APOPTOSIS; CROHN DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

CROHN DISEASE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22;

EID: 85006219624     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2015.00095     Document Type: Review

References (38)

1. Barrett, J. C., Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., et al. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962. doi: 10.1038/ng.175
2. Burn, G. L., Svensson, L., Sanchez-Blanco, C., Saini, M., and Cope, A. P. (2011). Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett. 585, 3689-3698. doi: 10.1016/j.febslet.2011.04.032
3. Cerosaletti, K., and Buckner, J. H. (2012). Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22. Rev. Diabet. Stud. 9, 188-200. doi: 10.1900/RDS.2012.9.188
4. Chistiakova, D. A., and Chistiakova, E. I. (2010). T-cell protein tyrosine phosphatase: a role in inflammation and autoimmunity. Int. J. Diabetes Mellit. 2, 114-118. doi: 10.1016/j.ijdm.2010.05.012
5. Espino-Paisan, L., de la Calle, H., Fernández-Arquero, M., Figueredo, M. A., de la Concha, E. G., Urcelay, E., et al. (2011). A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes. Immunogenetics 63, 255-258. doi: 10.1007/s00251-010-0500-x
6. Estus, J. L., and Family Investigation of Nephropathy Diabetes Research Group, Fardo, D. W. (2013). Combining genetic association study designs: a GWAS case study. Front. Genet. 4:186. doi: 10.3389/fgene.2013.00186
7. Francois, M. R. (2006). Final Report of the Epidemiologic Study of Crohn's Disease and Ulcerative Colitis. Bureau of Epidemiology, Florida Department of Health.
8. Fukushima, A., Loh, K., Galic, S., Fam, B., Shields, B., Wiede, F., et al. (2010). T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 59, 1906-1914. doi: 10.2337/db09-1365
9. Hermann, R., Lipponen, K., Kiviniemi, M., Kakko, T., Veijola, R., Simell, O., et al. (2006). Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 49, 1198-1208. doi: 10.1007/s00125-006-0225-4
10. Hober, D., and Sauter, P. (2010). Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6, 279-289. doi: 10.1038/nrendo.2010.27
11. Ladner, M. B., Bottini, N., Valdes, A. M., and Noble, J. A. (2005). Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum. Immunol. 66, 60-64. doi: 10.1016/j.humimm.2004.09.016
12. Maine, C. J., Hamilton-Williams, E. E., Cheung, J., Stanford, S. M., Bottini, N., Wicker, L. S., et al. (2012). PTPN22 alters the development of regulatory T cells in the thymus. J. Immunol. 188, 5267-5275. doi: 10.4049/jimmunol.1200150
13. McCole, D. F. (2012). Regulation of epithelial barrier function by the inflammatory bowel disease candidate gene, PTPN2. Ann. N. Y. Acad. Sci. 1257, 108-114. doi: 10.1111/j.1749-6632.2012.06522.x
14. Menard, L., Saadoun, D., Isnardi, I., Ng, Y. S., Meyers, G., Massad, C., et al. (2011). The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 121, 3635-3644. doi: 10.1172/JCI45790
15. Naser, S. A., Ghobrial, G., Romero, C., and Valentine, J. F. (2004). Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364, 1039-1044. doi: 10.1016/S0140-6736(04)17058-X
16. Naser, S. A., Schwartz, D., and Shafran, I. (2000). Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients. Am. J. Gastroenterol. 95, 1094-1095. doi: 10.1111/j.1572-0241.2000.01954.x
17. Naser, S. A., Thanigachalam, S., Dow, C. T., and Collins, M. T. (2013). Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study. Gut Pathog. 5:14. doi: 10.1186/1757-4749-5-14
18. Nazareth, N., Magro, F., Machado, E., Ribeiro, T. G., Martinho, A., Rodrigues, P., et al. (2015). Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med. Microbiol. Immunol. 204, 681-692. doi: 10.1007/s00430-015-0420-3
19. Osterman, M. T., and Lichtenstein, G. R. (2007). Current and future anti-TNF therapy for inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 10, 195-207. doi: 10.1007/s11938-007-0013-3
20. Qiu, Y. H., Deng, F. Y., Li, M. J., and Lei, S. F. (2014). Identification of novel risk genes associated with type 1 diabetes mellitus using a genome-wide gene-based association analysis. J. Diabetes Investig. 5, 649-656. doi: 10.1111/jdi.12228
21. Santin, I., Moore, F., Colli, M. L., Gurzov, E. N., Marselli, L., Marchetti, P., et al. (2011). PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60, 3279-3288. doi: 10.2337/db11-0758
22. Sartor, R. B. (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390-407. doi: 10.1038/ncpgasthep0528
23. Scharl, M., Mwinyi, J., Fischbeck, A., Leucht, K., Eloranta, J. J., Arikkat, J., et al. (2012a). Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm. Bowel Dis. 18, 900-912. doi: 10.1002/ibd.21913
24. Scharl, M., Paul, G., Weber, A., Jung, B. C., Docherty, M. J., Hausmann, M., et al. (2009). Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2. Gastroenterology 137, 2030-2040. e2035. doi: 10.1053/j.gastro.2009.07.078
25. Scharl, M., and Rogler, G. (2012). The role for protein tyrosine phosphatase nonreceptor type 2 in regulating autophagosome formation. Ann. N. Y. Acad. Sci. 1257, 93-102. doi: 10.1111/j.1749-6632.2012.06578.x
26. Scharl, M., Wojtal, K. A., Becker, H. M., Fischbeck, A., Frei, P., Arikkat, J., et al. (2012b). Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm. Bowel Dis. 18, 1287-1302. doi: 10.1002/ibd.21891
27. Smyth, D. J., Plagnol, V., Walker, N. M., Cooper, J. D., Downes, K., Yang, J. H., et al. (2008). Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767-2777. doi: 10.1056/NEJMoa0807917
28. Spalinger, M. R., Kasper, S., Chassard, C., Raselli, T., Frey-Wagner, I., Gottier, C., et al. (2015). PTPN2 controls differentiation of CD4(+) T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 8, 918-929. doi: 10.1038/mi.2014.122
29. Spalinger, M. R., Lang, S., Vavricka, S. R., Fried, M., Rogler, G., and Scharl, M. (2013a). Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy. PLoS ONE 8:e72384. doi: 10.1371/journal.pone.0072384
30. Spalinger, M. R., Lang, S., Weber, A., Frei, P., Fried, M., Rogler, G., et al. (2013b). Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-gamma-induced signaling in human monocytes. Gastroenterology 144, 978-988. e910. doi: 10.1053/j.gastro.2013.01.048
31. Todd, J. A. (2010). Etiology of type 1 diabetes. Immunity 32, 457-467. doi: 10.1016/j.immuni.2010.04.001
32. van Belle, T. L., Coppieters, K. T., and von Herrath, M. G. (2011). Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol. Rev. 91, 79-118. doi: 10.1152/physrev.00003.2010
33. Vang, T., Congia, M., Macis, M. D., Musumeci, L., Orrú, V., Zavattari, P., et al. (2005). Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37, 1317-1319. doi: 10.1038/ng1673
34. Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., and Nussenzweig, M. C. (2003). Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377. doi: 10.1126/science.1086907
35. Wiede, F., Ziegler, A., Zehn, D., and Tiganis, T. (2014). PTPN2 restrains CD8(+) T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice. J. Autoimmun. 53, 105-114. doi: 10.1016/j.jaut.2014.05.008
36. Wu, D. J., Zhou, W., Enouz, S., Orru, V., Stanford, S. M., Maine, C. J., et al. (2014). Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells. PLoS ONE 9:e86677. doi: 10.1371/journal.pone.0086677
37. Xi, Y., Liu, S., Bettaieb, A., Matsuo, K., Matsuo, I., Hosein, E., et al. (2015). Pancreatic T cell protein-tyrosine phosphatase deficiency affects beta cell function in mice. Diabetologia 58, 122-131. doi: 10.1007/s00125-014-3413-7
38. Zheng, P., and Kissler, S. (2013). PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes 62, 896-904. doi: 10.2337/db12-0929